Related Experiment Videos
The Fas ligand/Fas system in renal injury
Abstract:
The FasL-Fas system regulates renal cell apoptosis, as well as the immune and inflammatory responses. Evidence that FasL and Fas participate in renal injury may be summarized along modified Koch's postulates (Table 1): (i) FasL is expressed by renal cells and during renal injury, (ii) activation of the Fas receptor promotes apoptosis of cultured renal cells, (iii) Fas agonists induce glomerular injury but they may also decrease renal injury by limiting injurious immunological responses, (iv) mice with disrupted FasL/Fas systems are protected from tubular cell injury during ischaemia reperfusion, although they develop autoimmune glomerulonephritis if other genetic predisposing factors are present. FasL/Fas must be considered a new target for therapeutic intervention in renal injury. Therapeutic modulation of Fas should aim not only at protecting intrinsic glomerular or tubular epithelial cells from death, but also at modulating the immune, inflammatory, and fibrogenic responses. Possible therapeutic interventions include Fas agonists, soluble Fas receptors, or other antagonists, and targetting of Fas to undesired cells, such as fibroblasts, in order to decrease their numbers in a physiological manner through apoptosis. Any therapeutic attempt should carefully take into account the possible effects of interference with Fas in other 1833 cell systems. Given the complexities of the FasL/Fas system, further studies are warranted.
Insights
The FasL-Fas system plays a key role in kidney injury by regulating cell death and immune responses. Targeting this system offers a potential new therapeutic strategy for various kidney diseases.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- The Fas ligand (FasL) and Fas receptor system is crucial for regulating apoptosis, immune responses, and inflammation within the kidneys.
- Evidence suggests FasL and Fas are involved in renal injury, aligning with modified Koch's postulates.
Discussion:
- FasL expression by renal cells during injury and Fas activation promoting renal cell apoptosis highlight its role.
- Fas agonists can induce glomerular injury but may also mitigate renal damage by suppressing immune responses.
- Disruption of FasL/Fas systems protects against ischemic reperfusion injury but can lead to autoimmune glomerulonephritis in susceptible mice.
Key Insights:
- The FasL-Fas system represents a novel therapeutic target for managing renal injury.
- Therapeutic strategies should address both direct protection of renal cells and modulation of immune, inflammatory, and fibrogenic pathways.
- Potential interventions include Fas agonists, soluble Fas receptors, antagonists, and targeted apoptosis induction in specific cell types like fibroblasts.
Outlook:
- Careful consideration of systemic effects is necessary when modulating the FasL/Fas system due to its widespread influence.
- Further research is warranted to fully elucidate the complexities of the FasL/Fas system and optimize therapeutic interventions for renal diseases.